secwatch.observer — SEC 8-K summary
======================================

Issuer:     Silexion Therapeutics Corp (SLXN)
CIK:        0002022416
Form:       8-K
Filed at:   2026-03-25T23:59:59+00:00
Accession:  0001178913-26-001722
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Silexion Therapeutics removes director Ilan Levin effective March 25, 2026
--------------------------------------------------------------------------

- Ilan Levin removed from Board on March 25, 2026 by unanimous vote of other directors.
- Removal effective immediately; no reason disclosed in filing.
- No replacement director named or resignation reported.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2022416/000117891326001722/0001178913-26-001722-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2022416/000117891326001722/zk2634957.htm
  HTML page:      https://secwatch.observer/filing/0001178913-26-001722

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer